Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Stephen Brozak is an analyst at WBB Securities. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/29/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/05/2024 | CDTX | Buy Now | Cidara Therapeutics | $22.39 | 100.98% | Stephen Brozak77% | $40 → $45 | Maintains | Strong Buy | Get Alert |
| 04/25/2024 | CDTX | Buy Now | Cidara Therapeutics | $22.39 | 78.65% | Stephen Brozak77% | → $40 | Maintains | Strong Buy | Get Alert |
| 06/09/2020 | ARCT | Buy Now | Arcturus Therapeutics | $11.01 | 181.56% | Stephen Brozak77% | → $31 | Downgrade | Strong Buy → Hold | Get Alert |
| 01/08/2020 | PRTK | Buy Now | Paratek Pharmaceuticals | — | — | Stephen Brozak77% | → $6 | Initiates | → Speculative Buy | Get Alert |
| 09/20/2018 | ARCT | Buy Now | Arcturus Therapeutics | $11.01 | — | Stephen Brozak77% | — | Upgrade | Buy → Strong Buy | Get Alert |
| 05/30/2018 | TPIV | Buy Now | TapImmune | — | — | Stephen Brozak77% | — | Upgrade | Speculative Buy → Buy | Get Alert |
| 03/16/2018 | TPIV | Buy Now | TapImmune | — | — | Stephen Brozak77% | → $5 | Initiates | → Speculative Buy | Get Alert |
| 10/09/2017 | ADHD | Buy Now | Alcobra Ltd. - Ordinary Shares | — | — | Stephen Brozak77% | → $14 | Upgrade | Hold → Speculative Buy | Get Alert |
| 08/11/2017 | CDTX | Buy Now | Cidara Therapeutics | $22.39 | — | Stephen Brozak77% | — | Upgrade | Sell → Hold | Get Alert |
| 07/28/2017 | CDTX | Buy Now | Cidara Therapeutics | $22.39 | — | Stephen Brozak77% | — | Downgrade | Hold → Sell | Get Alert |
| 02/22/2017 | CDTX | Buy Now | Cidara Therapeutics | $22.39 | — | Stephen Brozak77% | — | Upgrade | Sell → Hold | Get Alert |
| 11/02/2016 | ADHD | Buy Now | Alcobra Ltd. - Ordinary Shares | — | — | Stephen Brozak77% | — | Upgrade | Sell → Hold | Get Alert |
| 09/23/2016 | CDTX | Buy Now | Cidara Therapeutics | $22.39 | — | Stephen Brozak77% | — | Downgrade | Hold → Sell | Get Alert |
| 09/12/2016 | ADHD | Buy Now | Alcobra | — | — | Stephen Brozak77% | — | Downgrade | Hold → Sell | Get Alert |
| 06/24/2015 | ADHD | Buy Now | Alcobra | — | — | Stephen Brozak77% | — | Downgrade | Speculative Buy → Hold | Get Alert |
| 06/26/2014 | ADHD | Buy Now | Alcobra Pharma | — | — | Stephen Brozak77% | → $126 | Initiates | → Hold | Get Alert |
| 01/22/2013 | PATH | Buy Now | NuPathe Inc. | $10.66 | — | Stephen Brozak77% | — | Upgrade | Buy → Strong Buy | Get Alert |
| 12/28/2012 | CEMP | Buy Now | Cempra, Inc. | — | — | Stephen Brozak77% | $50 → $60 | Upgrade | Buy → Strong Buy | Get Alert |
| 10/19/2012 | GIVN | Buy Now | Given Imaging | — | — | Stephen Brozak77% | — | Downgrade | Speculative Buy → Hold | Get Alert |
| 07/09/2012 | NBS | Buy Now | Neostem | — | — | Stephen Brozak77% | — | Upgrade | Buy → Strong Buy | Get Alert |
